TY - JOUR AU - Tullman, M. J. PY - 2013 DA - 2013// TI - Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis JO - Am J Manag Care VL - 19 ID - Tullman2013 ER - TY - JOUR AU - Bergvall, N. AU - Petrilla, A. A. AU - Karkare, S. U. AU - Lahoz, R. AU - Agashivala, N. AU - Pradhan, A. PY - 2014 DA - 2014// TI - Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis JO - J Med Econ VL - 17 UR - https://doi.org/10.3111/13696998.2014.940422 DO - 10.3111/13696998.2014.940422 ID - Bergvall2014 ER - TY - JOUR AU - Menzin, J. AU - Caon, C. AU - Nichols, C. AU - White, L. A. AU - Friedman, M. AU - Pill, M. W. PY - 2013 DA - 2013// TI - Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis JO - J Manag Care Pharm VL - 19 ID - Menzin2013 ER - TY - JOUR AU - Devonshire, V. AU - Lapierre, Y. AU - Macdonnel, R. AU - Ramo-Tello, C. AU - Patti, F. AU - Fontoura, P. PY - 2011 DA - 2011// TI - The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis JO - Eur J Neurol VL - 18 UR - https://doi.org/10.1111/j.1468-1331.2010.03110.x DO - 10.1111/j.1468-1331.2010.03110.x ID - Devonshire2011 ER - TY - JOUR AU - Agashivala, N. AU - Wu, N. AU - Abouzaid, S. AU - Wu, Y. AU - Kim, E. AU - Boulanger, L. PY - 2013 DA - 2013// TI - Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective study JO - BMC Neurol VL - 13 UR - https://doi.org/10.1186/1471-2377-13-138 DO - 10.1186/1471-2377-13-138 ID - Agashivala2013 ER - TY - JOUR AU - Wicks, P. AU - Massagli, M. AU - Kulkarni, A. AU - Dastani, H. PY - 2011 DA - 2011// TI - Online development of a tool to measure barriers to adherence: the multiple sclerosis treatment adherence questionnaire (MS-TAQ) JO - J Med Internet Res VL - 13 UR - https://doi.org/10.2196/jmir.1687 DO - 10.2196/jmir.1687 ID - Wicks2011 ER - TY - STD TI - Gilenya [package insert]. Stein (CH): Novartis Pharma Stein AG; 2012. ID - ref7 ER - TY - JOUR AU - Cohen, J. A. AU - Barkhof, F. AU - Comi, G. AU - Hartung, H. P. AU - Khatri, B. O. AU - Montalban, X. PY - 2010 DA - 2010// TI - TRANSFORMS study group. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0907839 DO - 10.1056/NEJMoa0907839 ID - Cohen2010 ER - TY - STD TI - Tecfidera. Cambridge (MA): Biogen Inc; 2013. ID - ref9 ER - TY - JOUR AU - Viglietta, V. AU - Miller, D. AU - Bar-Or, A. AU - Phillips, J. T. AU - Arnold, D. L. AU - Selmaj, K. PY - 2015 DA - 2015// TI - Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials JO - Ann Clin Transl Neurol VL - 2 UR - https://doi.org/10.1002/acn3.148 DO - 10.1002/acn3.148 ID - Viglietta2015 ER - TY - JOUR AU - Phillips, J. T. AU - Hutchinson, M. AU - Fox, R. AU - Gold, R. AU - Havrdova, E. PY - 2014 DA - 2014// TI - Managing flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: experiences of an international panel JO - Mult Scler Relat Disord VL - 3 UR - https://doi.org/10.1016/j.msard.2014.03.003 DO - 10.1016/j.msard.2014.03.003 ID - Phillips2014 ER - TY - JOUR AU - Ontaneda, D. AU - Hara-Cleaver, C. AU - Rudick, R. A. AU - Cohen, J. A. AU - Bermel, R. A. PY - 2012 DA - 2012// TI - Early tolerability and safety of fingolimod in clinical practice JO - J Neurol Sci VL - 323 UR - https://doi.org/10.1016/j.jns.2012.09.009 DO - 10.1016/j.jns.2012.09.009 ID - Ontaneda2012 ER - TY - JOUR AU - Atkinson, M. J. AU - Sinha, A. AU - Hass, S. L. AU - Colman, S. S. AU - Kumar, R. N. AU - Brod, M. PY - 2004 DA - 2004// TI - Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease JO - Health Qual Life Outcomes VL - 26 UR - https://doi.org/10.1186/1477-7525-2-12 DO - 10.1186/1477-7525-2-12 ID - Atkinson2004 ER - TY - JOUR AU - Wicks, P. AU - Vaughan, T. E. AU - Massagli, M. P. PY - 2012 DA - 2012// TI - The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community JO - Health Qual Life Outcomes VL - 18 UR - https://doi.org/10.1186/1477-7525-10-70 DO - 10.1186/1477-7525-10-70 ID - Wicks2012 ER - TY - JOUR AU - Bove, R. AU - Secor, E. AU - Healy, B. C. AU - Musallam, A. AU - Vaughan, T. AU - Glanz, B. I. PY - 2013 DA - 2013// TI - Evaluation of an online platform for multiple sclerosis research: patient description, validation of severity scale, and exploration of BMI effects on disease progression JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0059707 DO - 10.1371/journal.pone.0059707 ID - Bove2013 ER - TY - JOUR AU - Hohol, M. J. AU - Orav, E. J. AU - Weiner, H. L. PY - 1995 DA - 1995// TI - Disease steps in multiple sclerosis: a simple approach to evaluate disease progression JO - Neurology VL - 45 UR - https://doi.org/10.1212/WNL.45.2.251 DO - 10.1212/WNL.45.2.251 ID - Hohol1995 ER - TY - JOUR AU - Wicks, P. AU - Massagli, M. AU - Frost, J. AU - Brownstein, C. AU - Okun, S. AU - Vaughan, T. PY - 2010 DA - 2010// TI - Sharing health data for better outcomes on PatientsLikeMe JO - J Med Internet Res VL - 12 UR - https://doi.org/10.2196/jmir.1549 DO - 10.2196/jmir.1549 ID - Wicks2010 ER - TY - JOUR AU - Heinze, G. AU - Schemper, M. PY - 2002 DA - 2002// TI - A Solution to the problem of separation in logistic regression JO - Stat Med VL - 21 UR - https://doi.org/10.1002/sim.1047 DO - 10.1002/sim.1047 ID - Heinze2002 ER - TY - JOUR AU - Braithwaite, R. S. AU - Kozal, M. J. AU - Chang, C. C. AU - Roberts, M. S. AU - Fultz, S. L. AU - Goetz, M. B. PY - 2007 DA - 2007// TI - Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies JO - AIDS VL - 21 UR - https://doi.org/10.1097/QAD.0b013e3281532b31 DO - 10.1097/QAD.0b013e3281532b31 ID - Braithwaite2007 ER - TY - JOUR AU - Brod, M. AU - Rousculp, M. AU - Cameron, A. PY - 2008 DA - 2008// TI - Understanding compliance issues for daily self-injectable treatment in ambulatory care settings JO - Patient Prefer Adherence VL - 2 ID - Brod2008 ER - TY - JOUR AU - Conte, P. AU - Guarneri, V. PY - 2004 DA - 2004// TI - Safety of intravenous and oral bisphosphonates and compliance with dosing regimens JO - Oncologist VL - 9 UR - https://doi.org/10.1634/theoncologist.9-90004-28 DO - 10.1634/theoncologist.9-90004-28 ID - Conte2004 ER - TY - JOUR AU - Tan, H. AU - Cai, Q. AU - Agarwal, S. AU - Stephenson, J. J. AU - Kamat, S. PY - 2011 DA - 2011// TI - Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis JO - Adv Ther VL - 28 UR - https://doi.org/10.1007/s12325-010-0093-7 DO - 10.1007/s12325-010-0093-7 ID - Tan2011 ER - TY - JOUR AU - Steinberg, S. C. AU - Faris, R. J. AU - Chang, C. F. AU - Chan, A. AU - Tankersley, M. A. PY - 2010 DA - 2010// TI - Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study JO - Clin Drug Investig VL - 30 UR - https://doi.org/10.2165/11533330-000000000-00000 DO - 10.2165/11533330-000000000-00000 ID - Steinberg2010 ER -